U.S. jury hits Bayer with $81 million in Roundup cancer trial

A U.S. jury on Wednesday awarded $80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.